Table 1. Tumor incidence in limiting dilution assay.
Tumor incidence/injection | ||||
---|---|---|---|---|
Cells Injected | 1,000 | 100 | 10 | Estimated cancer stem cell frequency with confidence intervals (95%) |
4T1-DMSO | 10/10 | 10/10 | 7/10 | 1 in 9 (4-18) |
4T1-Benztropine mesylate | 8/10 | 7/10 | 5/10 | 1 in 218 (100-479)*** |
4T1-luc2 spheres pretreated with benztropine mesylate or DMSO were dissociated into single-cell suspensions and injected into the mammary fat pads of mice in limiting dilution (10; 100; 1,000). Tumor formation was observed for four weeks following inoculation. BCSC frequency was calculated using ELDA.